Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17499797)

Published in J Urol on May 17, 2007

Authors

Shunichi Namiki1, Seiichi Saito, Haruo Nakagawa, Takehiko Sanada, Atsushi Yamada, Yoichi Arai

Author Affiliations

1: Department of Urology, Tohoku University Graduate School of Medicine, Tohoku, Japan. namikin@uro.med.tohoku.ac.jp

Articles by these authors

Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer (2009) 2.64

The natural history of simple renal cysts. J Urol (2002) 2.40

Experience dictates stem cell fate in the adult hippocampus. Neuron (2011) 2.18

Current use of the artificial urinary sphincter and its long-term durability: a nationwide survey in Japan. Int J Urol (2009) 1.96

Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem (2004) 1.93

Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med (2009) 1.81

Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res (2007) 1.68

Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol (2013) 1.67

Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor. J Urol (2002) 1.61

Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg (2003) 1.61

Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer (2010) 1.58

Perioperative management of transurethral surgery for benign prostatic hyperplasia: a nationwide survey in Japan. Int J Urol (2011) 1.55

Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. Eur Urol (2004) 1.55

Nerves at the ventral prostatic capsule contribute to erectile function: initial electrophysiological assessment in humans. Eur Urol (2008) 1.53

Alterations in skin and stratified epithelia by constitutively activated PPARalpha. J Invest Dermatol (2006) 1.53

Risk factors for overactive bladder in the elderly population: a community-based study with face-to-face interview. Int J Urol (2010) 1.53

Association between physical activity and urinary incontinence in a community-based elderly population aged 70 years and over. Eur Urol (2007) 1.49

Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. J Cancer Res Clin Oncol (2009) 1.48

Laparoscopic simultaneous bilateral adrenalectomy: assessment of feasibility and potential indications. Int J Urol (2011) 1.46

Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol (2010) 1.42

Alveolar ridge notching as a predictor for secondary bone grafting in incomplete alveolar clefts. Cleft Palate Craniofac J (2004) 1.40

Surgical outcome of laparoscopic radical prostatectomy: summary of early multiinstitutional experience in Japan. Int J Clin Oncol (2003) 1.38

In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer (2005) 1.37

Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer (2008) 1.33

Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology (2004) 1.33

A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem (2005) 1.28

ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (2012) 1.28

Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer (2005) 1.23

The 10-year natural history of simple renal cysts. Urology (2008) 1.19

Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2006) 1.18

Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology (2005) 1.17

Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci (2009) 1.15

Nocturia and benign prostatic hyperplasia. Urology (2003) 1.13

Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol (2004) 1.10

Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol (2004) 1.10

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci (2004) 1.10

The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens (2006) 1.09

Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem (2006) 1.09

Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology (2005) 1.08

Novel IRF6 mutations in Japanese patients with Van der Woude syndrome: two missense mutations (R45Q and P396S) and a 17-kb deletion. J Hum Genet (2003) 1.07

Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. Jpn J Clin Oncol (2008) 1.06

Re: Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups: C. B. Anderson, M. R. Kaufman, M. S. Dietrich, D. A. Barocas, S. S. Chang, M. S. Cookson, J. A. Smith, Jr., P. E. Clark and S. D. Herrell J Urol 2012; 187: 1346-1351. J Urol (2012) 1.06

Novel immobilized zinc(II) affinity chromatography for phosphopeptides and phosphorylated proteins. J Sep Sci (2005) 1.06

High incidence of inguinal hernia after radical retropubic prostatectomy. Urology (2004) 1.05

Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Urology (2006) 1.05

Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer. Jpn J Clin Oncol (2009) 1.05

Analysis of salvage treatments following the failure of free flap transfer caused by vascular thrombosis in reconstruction for head and neck cancer. Plast Reconstr Surg (2007) 1.03

Treatment for prolapse of the sigmoid neovagina in Mayer-Rokitansky-Kuster-Hauser syndrome. Obstet Gynecol (2002) 1.03

Association between nonsyndromic cleft lip with or without cleft palate and the glutamic acid decarboxylase 67 gene in the Japanese population. Am J Med Genet A (2004) 1.02

Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Cancer Res (2003) 1.00

Essential mesenchymal role of small GTPase Rac1 in interdigital programmed cell death during limb development. Dev Biol (2009) 1.00

Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J (2008) 1.00

Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. Jpn J Clin Oncol (2004) 0.98

Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria. BJU Int (2013) 0.97

MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. Int J Oncol (2012) 0.97

Anatomical analysis of the neurovascular bundle supplying penile cavernous tissue to ensure a reliable nerve graft after radical prostatectomy. J Urol (2004) 0.96

Health-related quality of life in men with localized prostate cancer. Int J Urol (2009) 0.96

Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase. J Biol Chem (2003) 0.95

Acupuncture to Danzhong but not to Zhongting increases the cardiac vagal component of heart rate variability. Auton Neurosci (2011) 0.95

Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer. Prostate (2012) 0.95

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan. Radiat Oncol (2012) 0.95

Acute renal failure as a result of bilateral ureteral obstruction by Candida albicans fungus balls. Int J Urol (2006) 0.94

Enrichment of phosphorylated proteins from cell lysate using a novel phosphate-affinity chromatography at physiological pH. Proteomics (2006) 0.94

Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles. Toxicol Pathol (2003) 0.94

Primary choriocarcinoma in the posterior mediastinum. J Urol (2002) 0.94

Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology (2006) 0.93

Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol (2006) 0.93

N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res (2006) 0.93

Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis. J Cell Biol (2008) 0.92

Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate (2006) 0.92

Intraoperative electrophysiological confirmation of urinary continence after radical prostatectomy. J Urol (2005) 0.92

A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J (2003) 0.92

Paraneoplastic neurological and hematological syndromes associated with prostate cancer. Int J Urol (2012) 0.92

Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors. Int J Urol (2011) 0.92

Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int J Pharm (2007) 0.91

Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings. Pathol Int (2014) 0.91

Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab (2013) 0.91

Controversies associated with the evaluation of elderly men with localized prostate cancer when considering radical prostatectomy. Int J Clin Oncol (2014) 0.91

Laparoscopic nephropexy: treatment outcome and quality of life. Int J Urol (2004) 0.91

Symptom-specific quality of life in patients with benign prostatic hyperplasia. Int J Urol (2002) 0.91

Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment. Clin Cancer Res (2009) 0.91

Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer (2002) 0.91

Retroperitoneoscopy-assisted total nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology (2002) 0.90

Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. Glycobiology (2010) 0.90

Choice of flaps for breast reconstruction. Int J Clin Oncol (2005) 0.89

Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition). Int J Urol (2008) 0.89